Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Effect of L. Reuteri LM1063 on Sleep Health Improvement [NA]

View source ↗

Summary

A clinical trial evaluating the effect of Lactobacillus reuteri LM1063 on sleep health. The study is currently recruiting and sponsored by Lactomason Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri LM1063 (Lactobacillus reuteri LM1063)

Snippet

Sponsor: Lactomason Co., Ltd. | Conditions: Sleep Quality, Sleep Wake Disorders | NA | Status: RECRUITING